iGMDRD711

Canonical SMILES: C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2cc(F)ccc2F)Oc3cc(ccc3S1(=O)=O)C#CC4CCCC4

InChI: InChI=1S/C29H35F2N3O5S/c1-19-16-34(20(2)18-35)40(37,38)28-13-10-22(9-8-21-6-4-5-7-21)14-26(28)39-27(19)17-33(3)29(36)32-25-15-23(30)11-12-24(25)31/h10-15,19-21,27,35H,4-7,16-18H2,1-3H3,(H,32,36)/t19-,20+,27-/m0/s1

InChI Key: CROBQSVNIOLQSN-VKIDHGPPSA-N

Loading, please wait...
Standard Name
Pubchem CID
Drug Status
Standard NameBRD-K41597374
Pubchem CID54619300
Drug StatusAlone

Drug-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 3

Drug-gene pathway enrichments

1pid: LKB1 signaling events1pid: Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)1kegg: Thermogenesis - Homo sapiens (human)1kegg: Longevity regulating pathway - multiple species - Homo sapiens (human)1kegg: AMPK signaling pathway - Homo sapiens (human)1kegg: Longevity regulating pathway - Homo sapiens (human)1pid: mTOR signaling pathway1wikipathways: Target Of Rapamycin (TOR) Signaling1wikipathways: Pathways in clear cell renal cell carcinoma1wikipathways: Senescence and Autophagy in Cancer

Drug-gene GO enrichments

3CC: cytosol2BP: negative regulation of protein kinase activity2CC: TORC1 complex2BP: negative regulation of TOR signaling1CC: cytoplasm1MF: protein binding1CC: nucleoplasm1BP: neurotrophin TRK receptor signaling pathway1BP: TORC1 signaling1BP: regulation of apoptotic process

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
84335 AKT1S1 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Models in BRD-K41597374

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​

SITE
DATATYPES
CLASSFICATION
Map

Copyright © 2018 Modellab | All Rights Reserved

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.